FDA panel changing common health tests for women
Most women dread heading to the OBGYN but the process in the examination room may soon be changing.
This week, an FDA advisory panel voted to approve an HPV test that would replace the pap smear as the primary screening tool for cervical cancer for women over 25-years-old.
The test detects the DNA of HPV, unlike the pap test, which examines a cell sample under a microscope.
Studies show the HPV test can detect cancerous lesions better than traditional pap testing.
However, the pap smear will no go away entirely.
In most cases, the HPV test will be used in conjunction with the pap test.
Experts say the FDA is not required to follow the advice of the panel but it usually does.